Histopathologic Features in Relation to Pretreatment Tumor Growth in Patients with Glioblastoma

World Neurosurg. 2018 Jan:109:e50-e58. doi: 10.1016/j.wneu.2017.09.102. Epub 2017 Sep 23.

Abstract

Background: Rapid growth is a well-known property of glioblastoma (GBM); however, growth rates vary among patients. Mechanisms behind such variation have not been widely studied in human patients. We sought to investigate relationships between histopathologic features and tumor growth estimated from pretreatment magnetic resonance imaging scans.

Methods: In 106 patients with GBM, 2 preoperative T1-weighted magnetic resonance imaging scans obtained at least 14 days apart were segmented to assess tumor growth. A fitted Gompertzian growth curve based on the segmented volumes divided the tumors into 2 groups: faster and slower growth than expected based on the initial tumor volume. Histopathologic features were investigated for associations with these groups, using univariable and multivariable logistic regression analyses.

Results: The presence of high cellular density and thromboses was significantly associated with radiologic growth in the multivariable analysis (P = 0.018 and 0.019, respectively), with respective odds ratios of 3.0 (95% confidence interval, 1.2-7.4) and 4.3 (95% confidence interval, 1.3-14.5) for faster growing tumors.

Conclusions: Our findings show that high cellular density and thromboses are significant independent predictors of faster growth in human GBM. This finding underlines the importance of hypercellularity as a criterion in glioma grading. Furthermore, our findings are concordant with hypotheses suggesting hypoxia triggered by thromboses to be relevant for growth of GBM.

Keywords: Glioblastoma; Histopathology; Magnetic resonance imaging; Tumor biology; Tumor growth; Tumor hypoxia.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Brain Neoplasms / pathology*
  • Brain Neoplasms / therapy*
  • Female
  • Glioblastoma / pathology*
  • Glioblastoma / therapy*
  • Humans
  • Magnetic Resonance Imaging / methods
  • Male
  • Middle Aged
  • Retrospective Studies
  • Treatment Outcome
  • Tumor Burden*